EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII

Suleyman Akocak iD, Nebih Lolak iD, Andrea Ammara, Gökçenur Gürbüz, Ibrahim Bozgeyik, Demet Taşdemir, Hamada Hashem, Stefan Bräse, Claudiu T Supuran iD

ChemMedChem · 2026-07-14 · 21 (13)

DOI: 10.1002/cmdc.70369 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-07-06. Written by Suleyman Akocak and 8 co-authors. Institution: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Adıyaman University, Adıyaman, Türkiye. Major MEDLINE topics: Carbonic Anhydrase Inhibitors, Sulfonamides, Pyrazoles, Carbonic Anhydrases. Cited 2 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

A novel library of diazo and pyrazole‐carboxamide‐linked molecules containing the sulfonamide pharmacophore was developed and synthesized, yielding selective inhibitors of clinically relevant carbonic anhydrase (CA) isoforms. The synthesis method involved the production of diazonium salts from 4‐ and 3‐aminobenzenesulfonamide precursors, followed by cyclization and further functionalization to yield structurally diverse pyrazole derivatives. All compounds were evaluated for their inhibitory efficacy against hCA I and II (cytosolic isoforms) and the tumor‐associated isoenzymes hCA IX and XII; also, cytotoxicity and molecular modeling studies were conducted for the compounds. The newly synthesized hybrid compounds displayed extensive inhibitory activity, with most derivatives showing significant potency and selectivity for cancer‐associated isoforms. More specifically, para‐substituted analogs exhibited enhanced inhibitory properties relative to their meta‐substituted counterparts. Compound 5f , with a 3,4‐dichloro motif, exhibited the highest activity with a very low K I value of 1.8 nM against hCA IX, greatly surpassing the reference drug acetazolamide. Electron‐withdrawing substituents improved inhibitory efficacy, whereas electron‐donating groups often reduced activity. Furthermore, compounds 5f (A549: 41.17 μM; HCT116: 4.47 μM) and 6c (A549: 14.64 μM; HCT116: 4.03 μM) showed the lowest IC 50 values in both cell lines. The findings emphasize diazo‐ and pyrazole‐carboxamide‐linked benzenesulfonamides as promising scaffolds for advancing isoform‐selective carbonic anhydrase inhibitors.

Subjects

MeSH terms (MEDLINE)

Carbonic Anhydrase InhibitorsSulfonamidesPyrazolesCarbonic AnhydrasesHumansBenzenesulfonamidesStructure-Activity RelationshipCarbonic Anhydrase IIIsoenzymesAntigens, NeoplasmCarbonic Anhydrase IMolecular StructureCell Line, TumorCarbonic Anhydrase IXDose-Response Relationship, Drug

Author keywords

cancercarbonic anhydrasediazoisoformpyrazole‐carboxamide

Substances

Carbonic Anhydrase InhibitorsSulfonamidesPyrazolesCarbonic AnhydrasesBenzenesulfonamidesCarbonic Anhydrase IIIsoenzymesAntigens, NeoplasmpyrazoleCarbonic Anhydrase I

Authors and institutions

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Adıyaman University, Adıyaman, Türkiye.
  • Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Florence, Italy.
  • Faculty of Pharmacy, Adıyaman University, Adıyaman, Türkiye.
  • Department of Medical Biology, Faculty of Medicine, Adıyaman University, Adıyaman, Türkiye.
  • Department of Medical Biochemistry, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt.

ORCID profiles: Suleyman Akocak, Nebih Lolak, Claudiu T Supuran

Funding

  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Cite

APA

Akocak, S., Lolak, N., Ammara, A., Gürbüz, G., Bozgeyik, I., Taşdemir, D., Hashem, H., Bräse, S., & Supuran, C. T. (2026). Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII. ChemMedChem, 21(13). https://doi.org/10.1002/cmdc.70369

Vancouver

Akocak S, Lolak N, Ammara A, Gürbüz G, Bozgeyik I, Taşdemir D, et al. Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII. ChemMedChem. 2026;21(13). doi:10.1002/cmdc.70369

BibTeX
@article{Akocak2026,
  author = {Akocak, Suleyman and Lolak, Nebih and Ammara, Andrea and Gürbüz, Gökçenur and Bozgeyik, Ibrahim and Taşdemir, Demet and Hashem, Hamada and Bräse, Stefan and Supuran, Claudiu T},
  title = {Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {13},
  doi = {10.1002/cmdc.70369}
}
Start for free →